Wise AI, a K-OTC listed artificial intelligence (AI) platform company, announced on the 26th that it has signed a business agreement (MOU) and consulting contract with the global medical education and consulting organization 'Medical Career Research Institute' for the purpose of enhancing AI solutions and strengthening its penetration into the aesthetic medical market.
This agreement aims to improve the technology and service perfection of WiseAI's AI medical care platform 'AiU', as well as expand its influence in the domestic and international aesthetic medical market through joint sales and marketing activities centered on plastic surgery and dermatology.
The two companies plan to continue to work together to further refine AU’s customized medical institution functions by combining their respective business and technical capabilities and to effectively utilize them in actual medical settings. In particular, they plan to pursue advanced functions centered on practice based on the Medical Career Research Institute’s professional plastic surgery and dermatology consulting know-how.
In addition, the two companies plan to jointly participate in various seminars and academic events, as well as conduct sales activities utilizing their networks with existing consulting hospitals. Through this, they plan to focus on rapid market expansion centered on plastic surgery and dermatology and increasing the service adoption rate.
With this agreement, Wise AI will begin to introduce AU's AI solutions to the dermatology and plastic surgery fields in earnest, and aims to supply its AI solutions to over 1,000 hospitals and clinics targeting the top 10 departments within the year.
Jaeyoung Ryu, Head of Business Development at Wise AI, said, “AI is a solution that can simultaneously increase hospital operational efficiency and patient satisfaction by automating everything from consultations, reservations, and aftercare to personalized patient communication.” He added, “We will continue to expand the distribution of AI through collaboration with various partners and leap forward as a leader in the medical AI platform market.”
- See more related articles
You must be logged in to post a comment.